• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MTA2 敲低通过抑制 uPA 表达抑制人骨肉瘤转移。

MTA2 knockdown suppresses human osteosarcoma metastasis by inhibiting uPA expression.

机构信息

Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan.

出版信息

Aging (Albany NY). 2024 Sep 6;16(17):12239-12251. doi: 10.18632/aging.206070.

DOI:10.18632/aging.206070
PMID:39248711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11424574/
Abstract

The relationship between metastasis-associated protein 2 (MTA2) overexpression and tumor growth and metastasis has been extensively studied in a variety of tumor cells but not in human osteosarcoma cells. This study aims to elucidate the clinical significance, underlying molecular mechanisms, and biological functions of MTA2 in human osteosarcoma and . Our results show that MTA2 was elevated in osteosarcoma cell lines and osteosarcoma tissues and was associated with tumor stage and overall survival of osteosarcoma patients. Knockdown of MTA2 inhibited osteosarcoma cell migration and invasion by reducing the expression of urokinase-type plasminogen activator (uPA). Bioinformatic analysis demonstrated that high levels of uPA in human osteosarcoma tissues correlated positively with MTA2 expression. Furthermore, treatment with recombinant human uPA (Rh-uPA) caused significant restoration of OS cell migration and invasion in MTA2 knockdown osteosarcoma cells. We found that ERK1/2 depletion increased the expression of uPA, facilitating osteosarcoma cell migration and invasion. Finally, MTA2 depletion significantly reduced tumor metastasis and the formation of lung nodules . Overall, our study suggests that MTA2 knockdown suppresses osteosarcoma cell metastasis by decreasing uPA expression via ERK signaling. This finding provides new insight into potential treatment strategies against osteosarcoma metastasis by targeting MTA2.

摘要

转移相关蛋白 2(MTA2)过表达与肿瘤生长和转移之间的关系已在多种肿瘤细胞中得到广泛研究,但在人骨肉瘤细胞中尚未研究。本研究旨在阐明 MTA2 在人骨肉瘤中的临床意义、潜在分子机制和生物学功能。我们的结果表明,MTA2 在骨肉瘤细胞系和骨肉瘤组织中升高,并与骨肉瘤患者的肿瘤分期和总生存率相关。MTA2 的敲低通过降低尿激酶型纤溶酶原激活物(uPA)的表达抑制骨肉瘤细胞的迁移和侵袭。生物信息学分析表明,人骨肉瘤组织中高水平的 uPA 与 MTA2 表达呈正相关。此外,用重组人 uPA(Rh-uPA)处理导致 MTA2 敲低的骨肉瘤细胞中 OS 细胞迁移和侵袭的显著恢复。我们发现 ERK1/2 耗竭增加了 uPA 的表达,促进了骨肉瘤细胞的迁移和侵袭。最后,MTA2 的耗竭显著减少了肿瘤转移和肺结节的形成。总体而言,我们的研究表明,MTA2 的敲低通过 ERK 信号通路降低 uPA 表达抑制骨肉瘤细胞的转移。这一发现为通过靶向 MTA2 针对骨肉瘤转移的潜在治疗策略提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/fdc826f12629/aging-16-206070-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/d24cf9cd9f03/aging-16-206070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/f58cd708d03b/aging-16-206070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/dfc483a871ea/aging-16-206070-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/0f7f3d8acd6a/aging-16-206070-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/1526ad409a2a/aging-16-206070-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/fdc826f12629/aging-16-206070-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/d24cf9cd9f03/aging-16-206070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/f58cd708d03b/aging-16-206070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/dfc483a871ea/aging-16-206070-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/0f7f3d8acd6a/aging-16-206070-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/1526ad409a2a/aging-16-206070-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ad/11424574/fdc826f12629/aging-16-206070-g006.jpg

相似文献

1
MTA2 knockdown suppresses human osteosarcoma metastasis by inhibiting uPA expression.MTA2 敲低通过抑制 uPA 表达抑制人骨肉瘤转移。
Aging (Albany NY). 2024 Sep 6;16(17):12239-12251. doi: 10.18632/aging.206070.
2
Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.骨肉瘤从非转移表型向转移表型的进展与自分泌和旁分泌尿激酶型纤溶酶原激活物(uPA)轴的激活存在因果关联。
PLoS One. 2015 Aug 28;10(8):e0133592. doi: 10.1371/journal.pone.0133592. eCollection 2015.
3
Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.山奈酚通过抑制 U-2 OS 人骨肉瘤细胞中的 ERK-p38-JNK 和 AP-1 信号通路抑制细胞转移。
Oncol Rep. 2013 Aug;30(2):925-32. doi: 10.3892/or.2013.2490. Epub 2013 May 23.
4
MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1.MTA2 促进胃癌细胞侵袭,其转录受到 Sp1 的调控。
Mol Cancer. 2013 Sep 8;12(1):102. doi: 10.1186/1476-4598-12-102.
5
Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition.二氢杨梅素通过 SP-1 和 NF-κB 调控的尿激酶纤溶酶原激活物抑制抑制人骨肉瘤细胞转移。
Phytomedicine. 2021 Sep;90:153642. doi: 10.1016/j.phymed.2021.153642. Epub 2021 Jun 26.
6
Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.转移肿瘤相关蛋白-2基因敲低抑制人胶质瘤细胞在体外和体内的增殖与侵袭。
J Neurooncol. 2014 Nov;120(2):273-81. doi: 10.1007/s11060-014-1558-3. Epub 2014 Jul 22.
7
Loss of MTA2-mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK-MMP7 axis.MTA2介导的PTK7下调缺失通过调节FAK-MMP7轴抑制肝癌转移进程。
Environ Toxicol. 2024 Apr;39(4):1897-1908. doi: 10.1002/tox.24073. Epub 2023 Dec 5.
8
ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.锌指蛋白 692 通过 TNK2 介导的 MEK/ERK 通路激活促进骨肉瘤细胞的增殖、迁移和侵袭。
Biol Direct. 2024 Apr 22;19(1):28. doi: 10.1186/s13062-024-00472-3.
9
RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.RNA干扰介导的尿激酶型纤溶酶原激活剂及尿激酶型纤溶酶原激活剂受体的敲低可抑制前列腺癌细胞的侵袭、存活及体内致瘤性。
J Biol Chem. 2005 Oct 28;280(43):36529-40. doi: 10.1074/jbc.M503111200. Epub 2005 Aug 26.
10
Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.转移相关蛋白 2 通过调节 ERK/AKT 和 VEGF 信号通路促进非小细胞肺癌的转移。
Mol Med Rep. 2018 Apr;17(4):4899-4908. doi: 10.3892/mmr.2018.8535. Epub 2018 Feb 1.

本文引用的文献

1
ANP32A Knockdown Attenuates the Malignant Biological Behavior of Colorectal Cancer Cells by Suppressing Epithelial-mesenchymal Transition and ERK Activation.敲低ANP32A通过抑制上皮-间质转化和ERK激活减弱结肠癌细胞的恶性生物学行为。
J Cancer. 2023 Sep 4;14(15):2759-2770. doi: 10.7150/jca.84687. eCollection 2023.
2
EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression.EMP3作为miR-663a调控的关键下游靶点,干扰MAPK/ERK信号通路以抑制胆囊癌进展。
Cancer Lett. 2023 Oct 28;575:216398. doi: 10.1016/j.canlet.2023.216398. Epub 2023 Sep 18.
3
Advances in Osteosarcoma.
骨肉瘤的研究进展。
Curr Osteoporos Rep. 2023 Aug;21(4):330-343. doi: 10.1007/s11914-023-00803-9. Epub 2023 Jun 17.
4
Cellular and Genetic Background of Osteosarcoma.骨肉瘤的细胞与遗传背景
Curr Issues Mol Biol. 2023 May 15;45(5):4344-4358. doi: 10.3390/cimb45050276.
5
The interaction between osteosarcoma and other cells in the bone microenvironment: From mechanism to clinical applications.骨肉瘤与骨微环境中其他细胞之间的相互作用:从机制到临床应用
Front Cell Dev Biol. 2023 May 3;11:1123065. doi: 10.3389/fcell.2023.1123065. eCollection 2023.
6
Systematic review of craniofacial osteosarcoma regarding different clinical, therapeutic and prognostic parameters.关于不同临床、治疗和预后参数的颅面部骨肉瘤的系统评价。
Front Oncol. 2023 Mar 24;13:1006622. doi: 10.3389/fonc.2023.1006622. eCollection 2023.
7
MTA2 is one of 14 Transcription factors predicting recurrence free survival in gastric cancer and promotes cancer progression by targeting MCM5.MTA2是预测胃癌无复发生存率的14种转录因子之一,它通过靶向MCM5促进癌症进展。
J Cancer. 2023 Jan 1;14(2):262-274. doi: 10.7150/jca.77402. eCollection 2023.
8
Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK-ERK Pathway.脂质运载蛋白-2通过MEK-ERK途径抑制MET表达从而抑制骨肉瘤细胞转移。
Cancers (Basel). 2021 Jun 25;13(13):3181. doi: 10.3390/cancers13133181.
9
MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis.MTA2 沉默通过 ASK1/MEK3/p38/YB1 轴抑制 AP1 介导体 MMP12 的表达来减弱宫颈癌细胞的转移潜力。
Cell Death Dis. 2021 May 6;12(5):451. doi: 10.1038/s41419-021-03729-1.
10
Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy.肿瘤微环境中的纤溶酶和纤溶酶原系统:对癌症诊断、预后及治疗的意义
Cancers (Basel). 2021 Apr 12;13(8):1838. doi: 10.3390/cancers13081838.